E. Manseau

发表

Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization.

R. Clark, J. Lanigan, P. Dellapelle, 1982, The Journal of investigative dermatology.

Osteopontin expression and distribution in human carcinomas.

E. Manseau, H. Dvorak, B. Berse, 1994, The American journal of pathology.

Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels

Harold E. Dvorak, E. Manseau, H. Dvorak, 1991, The Journal of experimental medicine.

VEGF-A induces angiogenesis, arteriogenesis, lymphangiogenesis, and vascular malformations.

E. Manseau, H. Dvorak, J. Nagy, 2002, Cold Spring Harbor symposia on quantitative biology.

Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery.

E. Manseau, H. Dvorak, J. Nagy, 2001, The American journal of pathology.

Vascular Permeability Factor/Vascular Endothelial Growth Factor Induces Lymphangiogenesis as well as Angiogenesis

E. Manseau, H. Dvorak, M. Detmar, 2002, The Journal of experimental medicine.

Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression.

E. Manseau, H. Dvorak, A. Dvorak, 1979, Journal of the National Cancer Institute.

Systemic expression of cutaneous basophil hypersensitivity.

E. Manseau, H. Dvorak, R. Colvin, 1977, Journal of immunology.

Rapamycin Inhibition of the Akt/mTOR Pathway Blocks Select Stages of VEGF-A164–Driven Angiogenesis, in Part by Blocking S6Kinase

Q. Xue, E. Manseau, H. Dvorak, 2009, Arteriosclerosis, thrombosis, and vascular biology.

Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.

E. Manseau, H. Dvorak, R. Jackman, 1995, Journal of Immunology.

Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response

M. Mihm, E. Manseau, H. Dvorak, 1979, The Journal of experimental medicine.

Experimental toxic cirrhosis in the rat. II. Kinetics of hepatocyte proliferation during intermittent thioacetamide intoxication.

E. Manseau, S. M. Shea, 1968, American Journal of Pathology.

Osteopontin is strongly expressed by histiocytes in granulomas of diverse etiology.

E. Manseau, H. Dvorak, L. Brown, 1997, Laboratory investigation; a journal of technical methods and pathology.

Human breast carcinoma: fibrin deposits and desmoplasia. Inflammatory cell type and distribution. Microvasculature and infarction.

E. Manseau, H. Dvorak, A. Dvorak, 1981, Journal of the National Cancer Institute.

Blood Group and HLA Serotyping of Skin Allografi Donors and Recipients

E. Manseau, S. Galli, Benjamin, 2003 .

Ulceration is correlated with degradation of fibrin and fibronectin at the corneal surface.

E. Manseau, M. Berman, D. Aiken, 1983, Investigative ophthalmology & visual science.

Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces.

E. Manseau, H. Dvorak, B. Berse, 1992, Molecular biology of the cell.

Morphology of delayed type hypersensitivity reactions in man. I. Quantitative description of the inflammatory response.

M. Mihm, E. Manseau, H. Dvorak, 1974, Laboratory investigation; a journal of technical methods and pathology.

Vascular permeability factor mRNA and protein expression in human kidney.

E. Manseau, H. Dvorak, B. Berse, 1992, Kidney international.

The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor

Janice A. Nagy, D. Mukhopadhyay, E. Manseau, 2001, Nature Medicine.

Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing.

R. Clark, J. Lanigan, P. Dellapelle, 1982, The Journal of investigative dermatology.

Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.

E. Manseau, H. Dvorak, R. Jackman, 1993, Cancer research.

Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining.

E. Manseau, H. Dvorak, J. Nagy, 1995, Cancer research.

Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas.

E. Manseau, H. Dvorak, R. Jackman, 1993, The American journal of pathology.

Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.

D. Mukhopadhyay, E. Manseau, H. Dvorak, 1998, Cancer research.

Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development.

E. Manseau, H. Dvorak, L. Brown, 1995, American Journal of Pathology.

HETEROGENEITY OF THE CELLULAR IMMUNE RESPONSE

R. Bast, E. Manseau, H. Dvorak, 1971, The Journal of experimental medicine.

Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis.

E. Manseau, H. Dvorak, K. Claffey, 1996, Cancer research.

Pathogenesis of desmoplasia. I. Immunofluorescence identification and localization of some structural proteins of line 1 and line 10 guinea pig tumors and of healing wounds.

E. Manseau, H. Dvorak, B. Smith, 1984, Journal of the National Cancer Institute.

Expression of Vascular Permeability Factor! Vascular Endothelial Growth Factor by Human Granulosa and Theca Lutein Cells Role in Corpus Luteum Development

E. Manseau, H. Dvorak, L. Brown, 2007 .

Ultrastructural Localization of the Vascular Permeability Factor/Vascular Endothelial Growth Factor (VPF/VEGF) Receptor-2 (FLK-1, KDR) in Normal Mouse Kidney and in the Hyperpermeable Vessels Induced by VPF/VEGF-expressing Tumors and Adenoviral Vectors

P E Thorpe, E. Manseau, H. Dvorak, 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases.

K. Shulman, E. Manseau, L. Brown, 1996, Journal of the American Society of Nephrology : JASN.

The Journal of Experimental Medicine CORRESPONDENCE

E. Manseau, H. Dvorak, J. Nagy, 2005 .

Orphan nuclear receptor TR 3 / Nur 77 regulates VEGF-A – induced angiogenesis through its transcriptional activity

E. Manseau, H. Dvorak, J. Nagy, 2006 .

Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.

J. Niloff, E. Manseau, H. Dvorak, 1996, Laboratory investigation; a journal of technical methods and pathology.

Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor

Dian Feng, E. Manseau, H. Dvorak, 2000, Laboratory Investigation.

Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces.

E. Manseau, H. Dvorak, B. Berse, 1992, Molecular biology of the cell.

Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.

D. Mukhopadhyay, E. Manseau, H. Dvorak, 1998, Cancer research.

Orphan nuclear receptor TR3/Nur77 regulates VEGF-A–induced angiogenesis through its transcriptional activity

E. Manseau, H. Dvorak, J. Nagy, 2006, The Journal of experimental medicine.